€38.93
1.21% today
Xetra, Sep 18, 05:15 pm CET
ISIN
NL0000240000
Symbol
QIA

Qiagen Stock price

€38.46
-3.70 8.78% 1M
+2.18 5.99% 6M
-5.81 13.13% YTD
-4.31 10.08% 1Y
-7.42 16.18% 3Y
-6.55 14.56% 5Y
+11.36 41.92% 10Y
+26.69 226.72% 20Y
Xetra, Closing price Wed, Sep 17 2025
+0.16 0.40%

Key metrics

Basic
Market capitalization
€8.3b
Enterprise Value
€8.7b
Net debt
€414.9m
Cash
€807.2m
Shares outstanding
216.8m
Valuation (TTM | estimate)
P/E
26.7 | 19.0
P/S
4.8 | 4.6
EV/Sales
5.1 | 4.9
EV/FCF
20.8
P/B
2.8
Dividends
DPS
€1.46
Yield 1Y | 5Y
3.8% | 1.2%
Growth 1Y | 5Y
16.3% | -
Payout 1Y | 3Y
391.4% | 38.9%
Increased
2 Years
Financials (TTM | estimate)
Revenue
€1.7b | €1.8b
EBITDA
€470.2m | €666.4m
EBIT
€463.7m | €506.1m
Net Income
€316.0m | €439.9m
Free Cash Flow
€419.7m
Growth (TTM | estimate)
Revenue
5.2% | 7.4%
EBITDA
20.6% | 56.1%
EBIT
21.8% | 20.8%
Net Income
413.6% | 521.8%
Free Cash Flow
22.4%
Margin (TTM | estimate)
Gross
64.2%
EBITDA
27.2% | 37.1%
EBIT
26.9%
Net
18.3% | 24.5%
Free Cash Flow
24.3%
Financial Health
Equity Ratio
62.7%
Return on Equity
2.3%
ROCE
11.7%
ROIC
8.9%
Debt/Equity
0.4
More
EPS
€1.4
FCF per Share
€1.9
Short interest
-
Employees
5k
Rev per Employee
€320.0k
Show more

Create a Free Account to create an Qiagen alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Qiagen Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Qiagen forecast:

13x Buy
54%
11x Hold
46%

Analyst Opinions

24 Analysts have issued a Qiagen forecast:

Buy
54%
Hold
46%

Financial data from Qiagen

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,726 1,726
5% 5%
100%
- Direct Costs 618 618
2% 2%
36%
1,108 1,108
7% 7%
64%
- Selling and Administrative Expenses 482 482
0% 0%
28%
- Research and Development Expense 156 156
5% 5%
9%
470 470
21% 21%
27%
- Depreciation and Amortization 6.58 6.58
28% 28%
0%
EBIT (Operating Income) EBIT 464 464
22% 22%
27%
Net Profit 316 316
414% 414%
18%

In millions EUR.

Don't miss a Thing! We will send you all news about Qiagen directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Head office United States
CEO Thierry Bernard
Employees 5,232
Founded 1996
Website www.qiagen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today